Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Contraindications for mannitol in aphakic glaucoma.

M T Grabie, R M Gipstein, D A Adams

    American Journal of Ophthalmology
    |February 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Further improving the cognitive effect profile of electroconvulsive therapy (ECT): the case for studying carbamylated erythropoietin.

    Medical hypotheses·2015
    Same author

    The barrier method: a technique for calculating very long transition times.

    The Journal of chemical physics·2010
    Same author

    Harmonic measure for critical Potts clusters.

    Physical review. E, Statistical, nonlinear, and soft matter physics·2009
    Same author

    Lipid Dynamics during the Spontaneous Reactivation of a Membranous Sialyltransferase Complex in Escherichia Coli K-235.

    Biophysical journal·2009
    Same author

    Power spectra of the total occupancy in the totally asymmetric simple exclusion process.

    Physical review letters·2007
    Same author

    Coarsening of "clouds" and dynamic scaling in a far-from-equilibrium model system.

    Physical review. E, Statistical, nonlinear, and soft matter physics·2007
    Same journal

    Reply to Comment on Visual Field Progression in Glaucoma Patients with Delayed Follow-Up.

    American journal of ophthalmology·2026
    Same journal

    Comment on: "Safety and efficiency reducing retinopathy of prematurity guideline sensitivity: an external validation using a large US-based dataset".

    American journal of ophthalmology·2026
    Same journal

    Reply to Comment on "Clinicopathological and Imaging Distinction Between Ocular Adnexal MALT Lymphoma and IgG4-Related Ophthalmic Disease".

    American journal of ophthalmology·2026
    Same journal

    Comment on: Visual Field Progression in Glaucoma Patients With Delayed Follow-Up.

    American journal of ophthalmology·2026
    Same journal

    Corneal sensitivity changes and nerve plexus abnormalities in noninfectious anterior uveitis.

    American journal of ophthalmology·2026
    Same journal

    Role of Menopausal Hormone Therapy on Strabismus, Strabismus Surgery, and Reoperation Rates.

    American journal of ophthalmology·2026
    See all related articles

    Physicians must monitor patients carefully when prescribing mannitol to lower intraocular pressure. Compromised renal function requires vigilant monitoring of electrolytes and urine output to prevent severe complications.

    Area of Science:

    • Nephrology
    • Ophthalmology

    Background:

    • Mannitol is commonly used to reduce intraocular pressure.
    • Its use requires careful consideration of potential adverse effects.

    Observation:

    • A case report details a 72-year-old woman who developed severe complications after mannitol administration.
    • These included obtundation, intractable pulmonary edema, acidemia, and irreversible renal insufficiency.

    Findings:

    • The patient's renal insufficiency persisted despite aggressive hemodialysis.
    • This highlights the critical risk associated with mannitol in patients with compromised renal function.

    Implications:

    • Physicians must exercise caution when prescribing mannitol, especially in patients with pre-existing or potential renal impairment.

    Related Experiment Videos

  • Close monitoring of electrolyte levels, daily urine output, and overall renal function is essential during mannitol therapy.